Variant report

Variant	nsv883093
Chromosome Location	chr5:164685326-164931799
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr5:164694025-164694205	K562	blood:	n/a	n/a
2	ATF1	chr5:164715567-164715708	K562	blood:	n/a	n/a
3	BACH1	chr5:164864550-164864613	K562	blood:	n/a	n/a
4	BATF	chr5:164903143-164903359	GM12878	blood:	n/a	n/a
5	CEBPB	chr5:164922861-164923162	Hela-S3	cervix:	n/a	chr5:164923011-164923020 chr5:164923009-164923022 chr5:164923011-164923020 chr5:164923009-164923022 chr5:164923011-164923020
6	CEBPB	chr5:164732106-164732417	HepG2	liver:	n/a	chr5:164732265-164732278 chr5:164732267-164732276 chr5:164732267-164732276 chr5:164732265-164732276 chr5:164732267-164732276 chr5:164732380-164732393 chr5:164732382-164732393 chr5:164732267-164732276
7	CEBPB	chr5:164915660-164916123	H1-hESC	embryonic stem cell:	n/a	chr5:164915962-164915971 chr5:164915962-164915971
8	CEBPB	chr5:164861216-164861411	K562	blood:	n/a	chr5:164861272-164861283
9	CEBPB	chr5:164802293-164802493	HepG2	liver:	n/a	n/a
10	CEBPB	chr5:164744121-164744203	A549	lung:	n/a	n/a
11	CEBPB	chr5:164789503-164789777	IMR90	lung:	n/a	chr5:164789670-164789683 chr5:164789670-164789683 chr5:164789671-164789682
12	CEBPB	chr5:164736288-164736505	A549	lung:	n/a	chr5:164736331-164736342 chr5:164736331-164736340
13	CEBPB	chr5:164702617-164702877	HepG2	liver:	n/a	chr5:164702740-164702751
14	CEBPB	chr5:164753010-164753210	K562	blood:	n/a	chr5:164753022-164753033
15	CEBPB	chr5:164732133-164732416	IMR90	lung:	n/a	chr5:164732265-164732278 chr5:164732267-164732276 chr5:164732267-164732276 chr5:164732265-164732276 chr5:164732267-164732276 chr5:164732380-164732393 chr5:164732382-164732393 chr5:164732267-164732276
16	CEBPB	chr5:164789633-164789692	K562	blood:	n/a	chr5:164789670-164789683 chr5:164789670-164789683 chr5:164789671-164789682
17	CEBPB	chr5:164915607-164915937	HepG2	liver:	n/a	n/a
18	CEBPB	chr5:164922842-164923202	A549	lung:	n/a	chr5:164923011-164923020 chr5:164923009-164923022 chr5:164923011-164923020 chr5:164923009-164923022 chr5:164923011-164923020
19	CEBPB	chr5:164832470-164832699	HepG2	liver:	n/a	chr5:164832540-164832551
20	CEBPB	chr5:164861133-164861426	A549	lung:	n/a	chr5:164861272-164861283
21	CEBPB	chr5:164915607-164916082	IMR90	lung:	n/a	chr5:164915962-164915971 chr5:164915962-164915971
22	CEBPB	chr5:164832456-164832677	IMR90	lung:	n/a	chr5:164832540-164832551
23	CEBPB	chr5:164732129-164732420	A549	lung:	n/a	chr5:164732265-164732278 chr5:164732267-164732276 chr5:164732267-164732276 chr5:164732265-164732276 chr5:164732267-164732276 chr5:164732380-164732393 chr5:164732382-164732393 chr5:164732267-164732276
24	CEBPB	chr5:164922820-164923210	IMR90	lung:	n/a	chr5:164923011-164923020 chr5:164923009-164923022 chr5:164923011-164923020 chr5:164923009-164923022 chr5:164923011-164923020
25	CEBPB	chr5:164802294-164802610	IMR90	lung:	n/a	n/a
26	CEBPB	chr5:164922842-164923205	HepG2	liver:	n/a	chr5:164923011-164923020 chr5:164923009-164923022 chr5:164923011-164923020 chr5:164923009-164923022 chr5:164923011-164923020
27	CEBPB	chr5:164861142-164861418	HepG2	liver:	n/a	chr5:164861272-164861283
28	CEBPB	chr5:164789547-164789785	Hela-S3	cervix:	n/a	chr5:164789670-164789683 chr5:164789670-164789683 chr5:164789671-164789682
29	CEBPB	chr5:164861105-164861449	IMR90	lung:	n/a	chr5:164861272-164861283
30	CEBPB	chr5:164752974-164753175	HepG2	liver:	n/a	chr5:164753022-164753033
31	CEBPB	chr5:164768330-164768420	H1-hESC	embryonic stem cell:	n/a	n/a
32	CEBPB	chr5:164789502-164789779	HepG2	liver:	n/a	chr5:164789670-164789683 chr5:164789670-164789683 chr5:164789671-164789682
33	CEBPB	chr5:164922832-164923211	H1-hESC	embryonic stem cell:	n/a	chr5:164923011-164923020 chr5:164923009-164923022 chr5:164923011-164923020 chr5:164923009-164923022 chr5:164923011-164923020
34	CEBPB	chr5:164915647-164915946	A549	lung:	n/a	n/a
35	CEBPB	chr5:164922854-164923166	MCF-7	breast:	n/a	chr5:164923011-164923020 chr5:164923009-164923022 chr5:164923011-164923020 chr5:164923009-164923022 chr5:164923011-164923020
36	CTCF	chr5:164924903-164924985	GM19239	blood:	n/a	chr5:164924909-164924918
37	CTCF	chr5:164784460-164784610	RPTEC	kidney:	n/a	n/a
38	CTCF	chr5:164741562-164741595	MCF-7	breast:	n/a	n/a
39	CTCF	chr5:164924780-164924930	HPAF	blood vessel:	n/a	chr5:164924909-164924918
40	CTCF	chr5:164713260-164713410	GM12866	blood:	n/a	n/a
41	CTCF	chr5:164884960-164885110	GM12872	blood:	n/a	chr5:164885069-164885090 chr5:164885074-164885092
42	CTCF	chr5:164885020-164885170	GM12874	blood:	n/a	chr5:164885069-164885090 chr5:164885074-164885092
43	CTCF	chr5:164884976-164885200	Pancreas_OC	pancreas:	n/a	chr5:164885069-164885090 chr5:164885074-164885092
44	CTCF	chr5:164884931-164885172	SK-N-SH_RA	brain:	n/a	chr5:164885069-164885090 chr5:164885074-164885092
45	CTCF	chr5:164884967-164885187	LNCaP	prostate:	n/a	chr5:164885069-164885090 chr5:164885074-164885092
46	CTCF	chr5:164884960-164885110	GM12875	blood:	n/a	chr5:164885069-164885090 chr5:164885074-164885092
47	CTCF	chr5:164885020-164885170	GM12871	blood:	n/a	chr5:164885069-164885090 chr5:164885074-164885092
48	CTCF	chr5:164884918-164885149	H1-hESC	embryonic stem cell:	n/a	chr5:164885069-164885090 chr5:164885074-164885092
49	CTCF	chr5:164884981-164885139	NHEK	skin:	n/a	chr5:164885069-164885090 chr5:164885074-164885092
50	CTCF	chr5:164885020-164885170	GM12873	blood:	n/a	chr5:164885069-164885090 chr5:164885074-164885092

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:164768524-164768574	SK-N-SH_RA	brain:	n/a
2	chr5:164685724-164685774	ECC-1	luminal epithelium:	n/a
3	chr5:164685724-164685774	HEEpiC	esophagus:	n/a
4	chr5:164884295-164884345	BE2_C	brain:	n/a
5	chr5:164884295-164884345	GM12878	blood:	n/a
6	chr5:164768524-164768574	HAEpiC	amniotic membrane:	n/a
7	chr5:164768524-164768574	HNPCEpiC	eye:	n/a
8	chr5:164685724-164685774	HCT-116	colon:	n/a
9	chr5:164884295-164884345	ProgFib	skin:	n/a
10	chr5:164768524-164768574	ECC-1	luminal epithelium:	n/a
11	chr5:164884295-164884345	NHDF-neo	bronchial:	n/a
12	chr5:164884295-164884345	Jurkat	blood:	n/a
13	chr5:164884295-164884345	PANC-1	pancreas:	n/a
14	chr5:164685724-164685774	BE2_C	brain:	n/a
15	chr5:164884295-164884345	AG04449	skin:	fetal
16	chr5:164884295-164884345	HRPEpiC	eye:	n/a
17	chr5:164884295-164884345	SK-N-SH	brain:	n/a
18	chr5:164768524-164768574	GM12891	blood:	n/a
19	chr5:164685724-164685774	HEK293	kidney:	embryo
20	chr5:164768524-164768574	IMR90	lung:	fetal
21	chr5:164768524-164768574	Hela-S3	cervix:	n/a
22	chr5:164685724-164685774	AG04449	skin:	fetal
23	chr5:164685724-164685774	HL-60	blood:	n/a
24	chr5:164768524-164768574	PrEC	prostate:	n/a
25	chr5:164884295-164884345	Hepatocyte	liver:	n/a
26	chr5:164884295-164884345	GM12891	blood:	n/a
27	chr5:164884295-164884345	NT2-D1	testis:	n/a
28	chr5:164768524-164768574	HCF	heart:	n/a
29	chr5:164884295-164884345	H1-hESC	embryonic stem cell:	embryo
30	chr5:164768524-164768574	AG09309	skin:	n/a
31	chr5:164685724-164685774	HCF	heart:	n/a
32	chr5:164685724-164685774	SK-N-SH	brain:	n/a
33	chr5:164685724-164685774	SAEC	small airway:	n/a
34	chr5:164884295-164884345	HMEC	breast:	n/a
35	chr5:164884295-164884345	AG09319	gingival:	n/a
36	chr5:164768524-164768574	HCM	heart:	n/a
37	chr5:164884295-164884345	HAEpiC	amniotic membrane:	n/a
38	chr5:164884295-164884345	HRCEpiC	kidney:	n/a
39	chr5:164768524-164768574	AoSMC	blood vessel:	n/a
40	chr5:164768524-164768574	HepG2	liver:	n/a
41	chr5:164884295-164884345	PFSK-1	brain:	n/a
42	chr5:164768524-164768574	HRPEpiC	eye:	n/a
43	chr5:164884295-164884345	HUVEC	blood vessel:	n/a
44	chr5:164768524-164768574	HEK293	kidney:	embryo
45	chr5:164768524-164768574	HRCEpiC	kidney:	n/a
46	chr5:164884295-164884345	AG04450	lung:	fetal
47	chr5:164884295-164884345	CMK	blood:	n/a
48	chr5:164768524-164768574	AG04450	lung:	fetal
49	chr5:164884295-164884345	SK-N-MC	brain:	n/a
50	chr5:164768524-164768574	AG09319	gingival:	n/a

No.	Distal block	Cell Line	Cell type
1	chr5:163440189..163440698-chr5:164884608..164885410,2	MCF-7	breast:
2	chr5:164895738..164898420-chr5:164899219..164901759,2	MCF-7	breast:
3	chr5:164456344..164456958-chr5:164924436..164925021,2	MCF-7	breast:
4	chr5:164895738..164898420-chr5:164899219..164901759,2	MCF-7	breast:
5	chr5:164456268..164457507-chr5:164884675..164886184,4	MCF-7	breast:
6	chr5:164845730..164847624-chr5:164851644..164853366,2	K562	blood:
7	chr5:164845730..164847624-chr5:164851644..164853366,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-NUDCD2-12	chr5:164702819-164703173	NONHSAT104954
2	lnc-ODZ2-2	chr5:164776036-164776056	ENSG00000253693.1

Variant related genes	Relation type
ENSG00000253693	TF binding region
ENSG00000253693	CpG island

Extended variants
information (count: 5011 )
Associated
traits (count: 80 )

Variant overlapped rSNPs/rCNVs (count:5011 , 50 per page) page: 1 2 3 4 5 6 7 ... 101

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs1541913	chr5:164685326-164685327	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
2	rs557604608	chr5:164685406-164685407	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
3	rs577556233	chr5:164685432-164685433	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
4	rs572913044	chr5:164685462-164685463	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
5	rs75064993	chr5:164685498-164685499	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
6	rs561353271	chr5:164685514-164685515	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
7	rs368205628	chr5:164685556-164685557	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
8	rs143158052	chr5:164685575-164685576	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
9	rs543573307	chr5:164685586-164685587	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
10	rs35728418	chr5:164685650-164685651	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
11	rs533006332	chr5:164685693-164685694	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
12	rs552623983	chr5:164685694-164685695	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
13	rs550824410	chr5:164685718-164685719	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
14	rs570821427	chr5:164685724-164685725	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
15	rs528618983	chr5:164685731-164685732	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
16	rs546966613	chr5:164685735-164685736	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
17	rs568472000	chr5:164685736-164685737	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
18	rs79814890	chr5:164685759-164685760	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
19	rs552310457	chr5:164685764-164685765	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
20	rs202031803	chr5:164685766-164685767	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
21	rs147481193	chr5:164685775-164685776	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
22	rs569420347	chr5:164685793-164685794	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
23	rs539613825	chr5:164685796-164685797	Enhancers Bivalent Enhancer	n/a	n/a	Overlapped CNVs	n/a
24	rs558354454	chr5:164685828-164685829	Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs77058013	chr5:164685874-164685875	Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs139166805	chr5:164685952-164685953	Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs113217323	chr5:164685966-164685967	Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs568896854	chr5:164686026-164686027	Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs374967149	chr5:164686029-164686030	Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs191644248	chr5:164686035-164686036	Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs573349958	chr5:164686041-164686042	Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs113918666	chr5:164686073-164686074	Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs370506647	chr5:164686074-164686075	Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs67841161	chr5:164686085-164686086	Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs199780996	chr5:164686093-164686094	Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs367652534	chr5:164686094-164686095	Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs61021963	chr5:164686099-164686100	Enhancers	n/a	n/a	Overlapped CNVs	n/a
38	rs533271522	chr5:164686100-164686101	Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs544847203	chr5:164686136-164686137	Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs149505243	chr5:164686173-164686174	Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs528551734	chr5:164686188-164686189	Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs547154547	chr5:164686229-164686230	Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs10070817	chr5:164686254-164686255	Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
44	rs568460284	chr5:164686275-164686276	Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs144011490	chr5:164686282-164686283	Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs550970761	chr5:164686301-164686302	Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs569423693	chr5:164686313-164686314	Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs148695321	chr5:164686314-164686315	Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs551645815	chr5:164686327-164686328	Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs566764517	chr5:164686367-164686368	Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:80)

Disease	PMID	Source
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Medulloblastoma	21979893	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Cancer	16751803	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Melanoma	18172304	CNVD
Glioma	20126413	CNVD
Cancer	22429812	CNVD
Cancer	21637783	CNVD
Colorectal cancer	20709793	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Liposarcoma	21253554	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Breast cancer	21858162	CNVD
Leukemia	17361228	CNVD
Myelodysplastic syndrome	18508791	CNVD
5q-syndrome	17576883	CNVD
Gastric cancer	17908304	CNVD
Lung cancer	16740712	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Urothelial carcinoma	21177765	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Barrett''s syndrome	19417022	CNVD
Lung cancer	18438408	CNVD
Thyroid cancer	19087340	CNVD
Breast cancer	21785460	CNVD
Breast cancer	17133270	CNVD
Acute myeloid leukemia	20729466	CNVD
lymphocytic leukemia	21291569	CNVD
Acute myeloid leukemia	21251322	CNVD
Multiple myeloma	17550852	CNVD
Salivary gland tumor	18059337	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Renal cell carcinoma	19377443	CNVD
Gastrointestinal stromal cancer	19259404	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Renal cell carcinoma	18592004	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Breast cancer	17603634	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Prostate cancer	18632612	CNVD
Ovarian cancer	21720365	CNVD
Myelofibrosis	22110671	CNVD
severe myoclonic epilepsy of infancy	18294202	CNVD
Olfactory neuroblastoma	18408657	CNVD
Esophageal squamous carcinoma	17470683	CNVD
Mental retardation	17124404	CNVD
epilepsy	18472482	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Non-syndromic sensorineural hearing loss	19587683	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD

Chromatin state (count:359 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:164684600-164688000	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
2	chr5:164685200-164685800	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr5:164685200-164685800	Enhancers	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
4	chr5:164685200-164686000	Enhancers	Fetal Brain Female	brain
5	chr5:164685200-164686400	Enhancers	Fetal Lung	lung
6	chr5:164685200-164687000	Enhancers	Brain Germinal Matrix	brain
7	chr5:164685400-164685800	Enhancers	H1 Cell Line	embryonic stem cell
8	chr5:164685400-164685800	Enhancers	H1 Derived Neuronal Progenitor Cultured Cells	ES cell derived
9	chr5:164685400-164685800	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
10	chr5:164685400-164685800	Enhancers	HUES6 Cell Line	embryonic stem cell
11	chr5:164685400-164685800	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
12	chr5:164685400-164686000	Enhancers	HUES64 Cell Line	embryonic stem cell
13	chr5:164685400-164686000	Enhancers	iPS-15b Cell Line	embryonic stem cell
14	chr5:164685400-164686000	Enhancers	iPS-18 Cell Line	embryonic stem cell
15	chr5:164685400-164686000	Enhancers	Ovary	ovary
16	chr5:164685400-164686200	Enhancers	Cortex derived primary cultured neurospheres	brain
17	chr5:164685400-164686400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
18	chr5:164685400-164686400	Enhancers	Fetal Stomach	stomach
19	chr5:164685600-164686200	Enhancers	HUES48 Cell Line	embryonic stem cell
20	chr5:164686400-164687600	Weak transcription	Fetal Lung	lung
21	chr5:164687000-164688400	Weak transcription	Brain Germinal Matrix	brain
22	chr5:164687800-164688000	Enhancers	Fetal Lung	lung
23	chr5:164688600-164688800	Enhancers	Brain Germinal Matrix	brain
24	chr5:164688800-164689000	Bivalent Enhancer	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
25	chr5:164690600-164691000	Enhancers	Fetal Kidney	kidney
26	chr5:164692000-164692200	Enhancers	H9 Cell Line	embryonic stem cell
27	chr5:164696400-164697200	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
28	chr5:164696400-164697200	Enhancers	Adipose Nuclei	Adipose
29	chr5:164709200-164709800	Enhancers	Primary hematopoietic stem cells short term culture	blood
30	chr5:164709200-164710000	Enhancers	Dnd41	blood
31	chr5:164709800-164711800	Weak transcription	Primary hematopoietic stem cells short term culture	blood
32	chr5:164711800-164712400	Enhancers	Primary hematopoietic stem cells short term culture	blood
33	chr5:164711800-164712400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
34	chr5:164712000-164712400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
35	chr5:164717000-164717400	Enhancers	Pancreatic Islets	Pancreatic Islet
36	chr5:164718400-164718800	Enhancers	HUES64 Cell Line	embryonic stem cell
37	chr5:164718800-164724000	Weak transcription	HUES64 Cell Line	embryonic stem cell
38	chr5:164723200-164724800	Enhancers	Primary neutrophils fromperipheralblood	blood
39	chr5:164724000-164724200	Enhancers	HUES64 Cell Line	embryonic stem cell
40	chr5:164724000-164724200	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
41	chr5:164724200-164724600	Enhancers	iPS-18 Cell Line	embryonic stem cell
42	chr5:164724200-164725000	Weak transcription	HUES64 Cell Line	embryonic stem cell
43	chr5:164724200-164736000	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
44	chr5:164725000-164725400	Enhancers	HUES64 Cell Line	embryonic stem cell
45	chr5:164729200-164729400	Enhancers	Pancreatic Islets	Pancreatic Islet
46	chr5:164729600-164731000	Weak transcription	Pancreatic Islets	Pancreatic Islet
47	chr5:164730400-164732400	Enhancers	Ovary	ovary
48	chr5:164730600-164733200	Enhancers	Fetal Lung	lung
49	chr5:164731000-164733600	Enhancers	Pancreatic Islets	Pancreatic Islet
50	chr5:164731200-164731600	Enhancers	Pancreas	Pancrea

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links